Novo Nordisk A/S ADR's ticker is and the CUSIP is K7314N152. A total of 1 filers reported holding Novo Nordisk A/S ADR in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $255,000 | +12.3% | 5,300 | 0.0% | 0.07% | +9.8% |
| Q2 2017 | $227,000 | +24.7% | 5,300 | 0.0% | 0.06% | +19.6% |
| Q1 2017 | $182,000 | -4.2% | 5,300 | 0.0% | 0.05% | -8.9% |
| Q4 2016 | $190,000 | -13.6% | 5,300 | 0.0% | 0.06% | -12.5% |
| Q3 2016 | $220,000 | -22.8% | 5,300 | 0.0% | 0.06% | -26.4% |
| Q2 2016 | $285,000 | -0.7% | 5,300 | 0.0% | 0.09% | +3.6% |
| Q1 2016 | $287,000 | -6.8% | 5,300 | 0.0% | 0.08% | -4.5% |
| Q4 2015 | $308,000 | +7.3% | 5,300 | 0.0% | 0.09% | +4.8% |
| Q3 2015 | $287,000 | -1.0% | 5,300 | 0.0% | 0.08% | +16.7% |
| Q2 2015 | $290,000 | +2.5% | 5,300 | 0.0% | 0.07% | -1.4% |
| Q1 2015 | $283,000 | +26.3% | 5,300 | 0.0% | 0.07% | +25.9% |
| Q4 2014 | $224,000 | -11.1% | 5,300 | 0.0% | 0.06% | -15.9% |
| Q3 2014 | $252,000 | +2.9% | 5,300 | 0.0% | 0.07% | +9.5% |
| Q2 2014 | $245,000 | +1.2% | 5,300 | 0.0% | 0.06% | +6.8% |
| Q1 2014 | $242,000 | +23.5% | 5,300 | +400.0% | 0.06% | +3.5% |
| Q4 2013 | $196,000 | +9.5% | 1,060 | 0.0% | 0.06% | -9.5% |
| Q3 2013 | $179,000 | – | 1,060 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stuart Chaussee & Associates, Inc. | 38 | $3,000 | 0.00% |